companydata.dkcompanydata.dk

CYTOVAC A/S: Financial statements 2023

CVR: 31262666

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

CYTOVAC A/S (CVR 31262666) has filed annual accounts for 2023. In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000. The company had 4 employees in the financial year.

Profit/Loss
DKK -15,319,000
Equity
DKK -88,579,000
Total Assets
DKK 6,427,000
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023---15.3M-88.6M4
20220--6.3M-73.3M8
2021960K--13.4M-67M-
20201M--15.7M-53.6M-
2019---34.1M-37.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

CYTOVAC A/S: The 2022 annual report is outJul 7, 2023

CYTOVAC A/S has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -6,277,000.

About CYTOVAC A/S

CYTOVAC A/S was a Danish company of the type Aktieselskab based in København K, founded in 2008. The company has been dissolved on 16 January 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 2 employees (2024). In 2023, the company reported a net result of DKK -15,319,000 compared with DKK -6,277,000 the year before. Equity in the 2023 report amounted to DKK -88,579,000.

Source: annual report 2023, Danish Business Authority